Smart immune cells take aim at tough blood cancers
Disease control
Ongoing
This early-stage trial tests a new therapy called SENTI-202, which uses specially designed immune cells (CAR NK cells) to find and attack cancer cells in people with certain blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The cells are 'off-the…
Phase: PHASE1 • Sponsor: Senti Biosciences • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC